Does Rallies show Form 4 insider transactions for RNAC?

Yes. Rallies tracks RNAC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RNAC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RNAC. It does not provide personalized investment advice.

RNAC (Cartesian Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Cartesian Therapeutics, Inc. Common Stock (RNAC) is a publicly traded Healthcare sector company. As of May 21, 2026, RNAC trades at $6.50 with a market cap of $202.44M and a P/E ratio of -1.27. RNAC moved +7.31% today. Year to date, RNAC is -5.64%; over the trailing twelve months it is -36.27%. Its 52-week range spans $5.60 to $26.50. Analyst consensus is strong buy with an average price target of $32.20. Rallies surfaces RNAC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RNAC stock inside the company?

Recent RNAC insider activity includes Brunn Carsten sold 23.77K, Miljkovic Milos sold 3.57K, Davis Blaine sold 10.59K, BARABE TIMOTHY C bought 30.00K, and SPRINGER TIMOTHY A bought 6.41K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

RNAC Key Metrics

Key financial metrics for RNAC
Metric	Value
Price	$6.50
Market Cap	$202.44M
P/E Ratio	-1.27
EPS	$-5.02
Dividend Yield	0.00%
52-Week High	$26.50
52-Week Low	$5.60
Volume	900
Avg Volume	0
Revenue (TTM)	$2.80M
Net Income	$-130.30M
Gross Margin	0.00%

Recent RNAC Insider Trades

Brunn Carsten sold 23.77K (~$162.08K) on Jan 6, 2026.
Miljkovic Milos sold 3.57K (~$24.37K) on Jan 6, 2026.
Davis Blaine sold 10.59K (~$72.23K) on Jan 6, 2026.
BARABE TIMOTHY C bought 30.00K (~$205.80K) on Dec 4, 2025.
SPRINGER TIMOTHY A bought 6.41K (~$69.07K) on Apr 11, 2025.

Latest RNAC News

Cartesian Reports $120.4M Cash, Advances Three Descartes-08 Trials — Apr 30, 2026

RNAC Analyst Consensus

6 analysts cover RNAC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.20.

Common questions about RNAC

Who is trading RNAC stock inside the company?: Recent RNAC insider activity includes Brunn Carsten sold 23.77K, Miljkovic Milos sold 3.57K, Davis Blaine sold 10.59K, BARABE TIMOTHY C bought 30.00K, and SPRINGER TIMOTHY A bought 6.41K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RNAC?: Yes. Rallies tracks RNAC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RNAC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RNAC. It does not provide personalized investment advice.